Results 31 to 40 of about 18,611 (183)

Clinical experience in an infant with Langerhans cell histiocytosis

Universidad Médica Pinareña, 2021
Introduction: Langerhans cell histiocytosis (LCH) or Histiocytosis X is a benign proliferative disease affecting dendritic cells. It presents a wide clinical spectrum, from isolated eosinophilic bone granuloma to multisystem involvement with multiple ...
Yamilka Pita Barrios, Surelys Peralta Santiesteban, César Adrián Blanco-Gómez   +2 more
doaj  

Indeterminate cell histocytosis with naïve cells

Rare Tumors, 2013
Histiocytoses are a heterogeneous group of disorders characterized by proliferation and accumulation of cells of mononuclearmacrophage system and dendritic cells.
Sheren F Younes, Mona A Kandil, Rehab M Samaka, Ola A Bakry   +3 more
doaj   +1 more source

The use of topical Rapamycin in successfully treating non-Langerhans cell histiocytosis in a pediatric patient

Journal of Skin and Sexually Transmitted Diseases
Non-Langerhans cell histiocytosis (non-LCH) refers to a collection of medical conditions distinguished by the excessive growth of histiocytes in bodily tissues. It is important to note that these conditions do not meet the established diagnostic criteria
David Pudukadan, Jeevana Mary Jose
semanticscholar   +1 more source

Erdheim-Chester disease detected with 99MTC MDP bone SPECT/CT

Journal of the Belgian Society of Radiology, 2012
Erdheim-Chester disease (ECD) is a rare non-Langerhans’ cell histiocytosis. Mild but permanent juxta-articular bone pain in mainly knees and ankles is the most frequent associated symptom.
G Ceulemans, M Keyaerts, L Verbruggen, A Hoorens, C Boulet, D Verdries, M De Maeseneer, B Ilsen, H Everaert   +8 more
doaj   +1 more source

Multiple adult xanthogranuloma: case report of successful treatment with CO2 Laser [PDF]

Surgical & Cosmetic Dermatology, 2020
Multiple adult xanthogranuloma is a rare and late variant of Juvenile xanthogranuloma, a non-Langerhans cell histiocytosis. It usually corresponds to a single lesion in adults, and the manifestation of multiples lesions is uncommon.
Alessandra Jaccottet Piriz, Elisângela de Quevedo Welter, Laura Luzzatto   +2 more
doaj   +1 more source

Juvenile xanthogranuloma of the cerebellopontine angle: A case report and review of the literature

Otolaryngology Case Reports, 2019
Juvenile xanthogranuloma (JXG) is a non-Langerhans cell histiocytosis, most often presenting with skin lesions of the head, neck, and upper trunk. Intracranial presentations have been previously described, however, due to its rarity, treatment algorithms
Sarah M. Tittman, Ashley M. Nassiri, Nauman F. Manzoor, Robert J. Yawn, Bret C. Mobley, John C. Wellons, III, Alejandro Rivas   +6 more
doaj   +1 more source

Histiocytosis: a review focusing on neuroimaging findings

Arquivos de Neuro-Psiquiatria, 2014
Objective: Histiocytosis is a systemic disease that usually affects the central nervous system. The aim of this study is to discuss the neuroimaging characteristics of Langerhans cell histiocytosis (LCH), the most common of these diseases; and the non ...
Larissa Barcessat Gabbay, Cláudia da Costa Leite, Ranieli Saraiva Andriola, Paula da Cunha Pinho, Leandro Tavares Lucato   +4 more
doaj   +1 more source

Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report [PDF]

Journal of Pathology and Translational Medicine, 2018
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis and multisystem disease. First described in 1930, there are no more than 750 cases reported.
Yeoun Eun Sung, Yoon Seo Lee, Jieun Lee, Kyo Young Lee   +3 more
doaj   +1 more source

Laryngeal involvement with fatal outcome in progressive nodular histiocytosis: A rare case report

Indian Dermatology Online Journal, 2016
Progressive nodular histiocytosis (PNH) represents a very rare type of non-Langerhans cell histiocytosis. It is characterized by progressive appearance of papules and nodules without spontaneous resolution.
Aarti Salunke, Vasudha Belgaumkar, Ravindranath Chavan, Rinkesh Dobariya   +3 more
doaj   +1 more source

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

Blood, 2019
Background: Activation of the MAPK pathway through BRAF mutations or other molecular alterations is a hallmark of the non-Lagerhans cell histiocytosis (non-LCH) such Erdheim-Chester disease (ECD) or Rosai-Dorfman disease (RDD).
F. Janku, H. Patel, Vaijayanthi Raghavan, A. Goodman, T. Barnes, R. Kurzrock   +5 more
semanticscholar   +1 more source